نتایج جستجو برای: radiosensitization

تعداد نتایج: 1347  

Journal: :Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 2014

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Yuji Seo Tao Yan Jane E Schupp Tomas Radivoyevitch Timothy J Kinsella

PURPOSE 5-Iodo-2-pyrimidinone-2'-deoxyribose (IPdR) is an oral prodrug of 5-iodo-2'-deoxyuridine (IUdR), an in vitro/in vivo radiosensitizer. IPdR can be rapidly converted to IUdR by a hepatic aldehyde oxidase. Previously, we found that the enzymatic conversion of IPdR to IUdR could be transiently reduced using a once daily (q.d.) treatment schedule and this may affect IPdR-mediated tumor radio...

Journal: :International Journal of Radiation Oncology*Biology*Physics 2017

2017
Vladimir A Kudryavtsev Anna V Khokhlova Vera A Mosina Elena I Selivanova Alexander E Kabakov

We studied a role of the inducible heat shock protein 70 (Hsp70) in cellular response to radiosensitizing treatments with inhibitors of the heat shock protein 90 (Hsp90) chaperone activity. Cell lines derived from solid tumors of different origin were treated with the Hsp90 inhibitors (17AAG, geldanamycin, radicicol, NVP-AUY922) or/and γ-photon radiation. For comparison, human cells of the non-...

Journal: :Journal of radiation research 2004
Natasja Castro Kreder Chris Van Bree Nicolaas A P Franken Jaap Haveman

The radiosensitizing potential of gemcitabine (2',2'-difluoro-2'-deoxycytidine) was studied in combination with pulsed low dose-rate irradiation. The experiments were carried out with a human lung carcinoma cell line SW1573. These were irradiated at pulsed low dose rate (p-LDR); the average dose rate was 1 Gy/h. In the experiments with gemcitabine, this drug was applied for 24 h at a concentrat...

Journal: :Molecular cancer therapeutics 2012
Terence M Williams Athena R Flecha Paul Keller Ashwin Ram David Karnak Stefanie Galbán Craig J Galbán Brian D Ross Theodore S Lawrence Alnawaz Rehemtulla Judith Sebolt-Leopold

There is an urgent need for the development of novel therapies to treat pancreatic cancer, which is among the most lethal of all cancers. KRAS-activating mutations, which are found in more than 90% of pancreatic adenocarcinomas, drive tumor dependency on the Ras/MAPK and Akt signaling pathways. Radiation is currently being explored as a component of the standard treatment regimen for pancreatic...

2012
Dan Zhang Hai-Bo Wang Kathryn L. Brinkman Su-Xia Han Bo Xu

The DNA damage response is critical for cells to maintain genome stability and survival. In this review, we discuss approaches to targeting critical elements of the DNA damage response for radiosensitization and chemosensitization. In addition, we also discuss strategies for targeting DNA damage response and DNA repair defects in cancer cells for synthetic lethality.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید